We are very excited today to announce a strategic collaboration with Bausch + Lomb to transform ophthalmology with precision medicine! Together, we aim to develop innovative treatments for age-related macular degeneration (AMD) by combining B+L's deep ophthalmology expertise with our AI-powered analytics platform. Read the full announcement: https://lnkd.in/eh2ppSAZ #CharacterBio #genomics #AMD #MacularDegeneration #PrecisionMedicine #biotech #ophthalmology #eyedisease #dryAMD #visionloss #AI #ArtificialIntelligence
Character Biosciences
Biotechnology
San Francisco, CA 5,256 followers
A patient-driven drug discovery platform for diseases of aging
About us
Character Biosciences (formerly Clover Therapeutics) is a precision medicine platform that is unlocking the patterns of age-related diseases in people of diverse backgrounds. Our mission is to use human genetics to understand what drives diseases so we can discover targeted therapies to more effectively treat patients - many of whom lack any treatment options today. Character partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines.
- Website
-
http://www.characterbio.com
External link for Character Biosciences
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- San Francisco, CA
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
Get directions
San Francisco, CA 94103, US
-
Get directions
155 2nd St
Jersey City, New Jersey 07302, US
-
Get directions
930 Brittan Ave
San Carlos, California 94070, US
Employees at Character Biosciences
Updates
-
We recently reached a significant milestone in our De-centralized Prospective Epidemiological Study of Progression of Age-related Macular Degeneration (AMD) Study by enrolling the first 5,000 patients! Upon reaching this important milestone, we shared with our study participants, research partners, and the general public updates and interim results. You can read those on our blog here: https://lnkd.in/etpyqPiN We thank each and every one of our participants for being a part of our mission to discover new treatments for AMD!
-
Welcome to the team Joe Davis! We are thrilled to announce that Dr. Joe Davis joins our team as Director of Data Science. Excited to see what you will accomplish!
-
-
We are thrilled to announce that Character Biosciences was selected to participate in Stanford University Graduate School of Business’s dy/dx program! Members of our management team have been in Palo Alto for the last three weeks learning from the incredible faculty and impressive cohort of founders and executives. Thank you to Stanford, Accel, Index Ventures, Lightspeed, Sequoia Capital, Innovation Endeavors for this transformative experience!
On Sunday we were overjoyed to welcome our third cohort of dy/dx at Stanford University Graduate School of Business with 53 leaders coming from 23 amazing startups! We have a diverse set of inspiring companies this year ranging from Seed to Series C and in various industries, from #gaming, to #robotics, to #petcare, and more, with of course a lot of #AI! A big thank you to our Venture Allies for continuing to support their founders through the dy/dx program! Accel, Index Ventures, Innovation Endeavors, Lightspeed, and Sequoia Capital #GSBExecEd #GSBdydx #startups
-
-
Happy Pride Month! At Character Biosciences, we recognize the invaluable contributions that LGBTQ+ scientists make in ophthalmology and all of STEM. To recognize LGBTQ+ scientists in STEM, Character Biosciences is giving back to Out in Science, Technology, Engineering & Mathematics (oSTEM), the largest chapter-based 501(c)(3) non-profit association dedicated to serving LGBTQ+ students and professionals around the world. We are proud to stand with the LGBTQ+ community and endeavor to build a vibrant and successful scientific community by embracing all individuals, regardless of sexual orientation or gender identity. Together we can create a society where everyone feels empowered to be their authentic selves, for Pride Month and beyond. Happy Pride Month from all of us at Character Bio! #LGBTQinSTEM #PrideMonth “Science is a universal language that transcends borders, cultures, and identities. It thrives on diversity, inclusivity, and equality.” -Graduate Women in Science, LA chapter
-
Look forward to take part in ARVO next week, and proud to share some the exciting work from the Character Bio labs!
We're thrilled to announce that we'll be presenting at ARVO 2024! 🌟 We can't wait to connect with you and share our latest advancements. Catch us at the following presentations, and feel free to view their abstracts attached below: 1️⃣ Poster B0216 - https://bit.ly/PosterB0216 2️⃣ Poster B1009 - https://bit.ly/PosterB1009 3️⃣ Presentation 6156 - https://lnkd.in/enhTMQKW #ARVO2024 #CharacterBio #AMD #VisionResearch #Ophthalmology
-
-
We're thrilled to announce that we'll be presenting at ARVO 2024! 🌟 We can't wait to connect with you and share our latest advancements. Catch us at the following presentations, and feel free to view their abstracts attached below: 1️⃣ Poster B0216 - https://bit.ly/PosterB0216 2️⃣ Poster B1009 - https://bit.ly/PosterB1009 3️⃣ Presentation 6156 - https://lnkd.in/enhTMQKW #ARVO2024 #CharacterBio #AMD #VisionResearch #Ophthalmology
-